Literature DB >> 47784

Pseudocyanotic pigmentation of the skin induced by amiodarone: a light and electron microscopic study.

C Delage, R Lagacé, J Huard.   

Abstract

An unusual bluish discolouration of the nose was noticed in a woman 9 months after she had begun treatment with a coronary vasodilator, amiodarone hydrochloride. Cutaneous biopsies of the nose were obtained 6 and 9 months later for light and electron microscopic studies. In the dermis were histiocytes containing cytoplasmic yellow-brown granules with histochemical properties of melanin and lipofuscin. Ultrastructurally the granules appeared as lysosomal membrane-bound dense bodies similar to lipofuscin. Similar granules were observed at diascopy in both corneas. The pathogenesis is obscure. A storage disease involving the drug or its metabolites cannot be ruled out. Another possibility is that amiodarone accelerates the normal cellular autophagocytosis, resulting in increased production of lipofuscin, which then accumulates in lysosomes because of a deficiency in lipolytic enzymes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 47784      PMCID: PMC1959100     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  19 in total

1.  PIGMENTATION FROM ANTIMALARIAL THERAPY. ITS POSSIBLE RELATIONSHIP TO THE OCULAR LESIONS.

Authors:  D TUFFANELLI; R K ABRAHAM; E I DUBOIS
Journal:  Arch Dermatol       Date:  1963-10

2.  The ocular complications of chloroquine therapy.

Authors:  H E HOBBS; C D CALNAN
Journal:  Lancet       Date:  1958-06-07       Impact factor: 79.321

3.  [Clinical and histological study (ultrastructure) of pigmentation due to aminodarone hydrochloride. (Interpretations and analogies)].

Authors:  P Morand; J Benatre; G Viau; C Carli-Basset; J L Laine; J L Neel; M Brochier; R Raynaud
Journal:  Sem Hop       Date:  1972-02-14

4.  [Treatment of angina pectoris with amiodarone].

Authors:  J Facquet; M Nivet; P Alhomme; S Raharison; Y Grosgogeat
Journal:  Presse Med       Date:  1969-04-19       Impact factor: 1.228

5.  [Clinical and histopathological development of skin pigment deposits appearing during treatment with amiodarone hydrochloride].

Authors:  G Balouet; F Labouche; R Daoulas; J P Leroy; D Picart; B Hery
Journal:  Arch Anat Pathol (Paris)       Date:  1972-09

6.  [Cutaneous pigmentation during treatments with amiodarone chlorhydrate].

Authors:  F Labouche; R Massé; A Jan; A Grullier; B Herry; A Bailleux
Journal:  Bull Soc Fr Dermatol Syphiligr       Date:  1971

7.  [Diseases due to drug deposits].

Authors:  P Fabiani
Journal:  Ann Biol Clin (Paris)       Date:  1972       Impact factor: 0.459

8.  A peculiar cutaneous pigmentation from cordarone.

Authors:  A K Vos; A G van Ramshorst; J C Grosfeld; J P Goossens
Journal:  Dermatologica       Date:  1972

9.  Fine structure of the skin in angiokeratoma corporis diffusum (Fabry's disease).

Authors:  P J van Mullem; M Ruiter
Journal:  J Pathol       Date:  1970-07       Impact factor: 7.996

10.  OCULAR COMPLICATIONS OF CHLOROQUINE THERAPY.

Authors:  L A LLOYD; J W HILTZ
Journal:  Can Med Assoc J       Date:  1965-03-06       Impact factor: 8.262

View more
  13 in total

1.  Blue man syndrome.

Authors:  Umjeet Jolly; George Klein
Journal:  CMAJ       Date:  2016-02-08       Impact factor: 8.262

2.  Amiodarone--an inhibitor of phospholipase activity: a comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine.

Authors:  N A Shaikh; E Downar; J Butany
Journal:  Mol Cell Biochem       Date:  1987-08       Impact factor: 3.396

3.  Control of recurrent supraventricular tachycardia with amiodarone hydrochloride.

Authors:  J H Swan; A W Chisholm
Journal:  Can Med Assoc J       Date:  1976-01-10       Impact factor: 8.262

4.  [Iatrogenic histopathological findings. A systematic compilation].

Authors:  R Vock
Journal:  Z Rechtsmed       Date:  1984

5.  Drug-induced lipidoses of the cornea and conjunctiva.

Authors:  D J D'Amico; K R Kenyon
Journal:  Int Ophthalmol       Date:  1981-08       Impact factor: 2.031

6.  Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity.

Authors:  M Stäubli; J Bircher; R L Galeazzi; H Remund; H Studer
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Progression of amiodarone induced cataracts.

Authors:  A J Flach; B J Dolan
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

8.  The QT interval: a predictor of the plasma and myocardial concentrations of amiodarone.

Authors:  N M Debbas; C du Cailar; R S Bexton; J G Demaille; A J Camm; P Puech
Journal:  Br Heart J       Date:  1984-03

9.  Amiodarone-induced lung toxicity. In vitro evidence for the direct toxicity of the drug.

Authors:  W J Martin; D M Howard
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

10.  Effects of chronic amiodarone treatment on cat myocardial phospholipid content and on in vitro phospholipid catabolism.

Authors:  N A Shaikh; E Downar
Journal:  Mol Cell Biochem       Date:  1987-11       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.